Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series

医学 中止 类风湿性关节炎 银屑病性关节炎 痹症科 内科学 肿瘤坏死因子α 风湿病 羟基氯喹 关节炎 免疫学 疾病 皮肤病科 传染病(医学专业) 2019年冠状病毒病(COVID-19)
作者
Daniela Oliveira,Ana Carolina Martins,F. Martins,C. Gomes,Sofia Pimenta,C. A. F. Vaz,Liane Correia‐Costa,Miguel Bernardes
出处
期刊:Reumatismo [PAGEPress Publications]
被引量:1
标识
DOI:10.4081/reumatismo.2024.1658
摘要

This case series aims to characterize the development of systemic lupus erythematosus (SLE) induced by anti-tumor necrosis factor α (anti-TNFα) therapy in patients with inflammatory rheumatic diseases, namely rheumatoid arthritis (RA), spondylarthritis (SpA), and psoriatic arthritis (PsA). Patients with a diagnosis of SLE induced by anti-TNFα therapy and registered on the Rheumatic Diseases Portuguese Register (Reuma.pt) who started their first anti-TNFα between 2001 and 2020 were included. Demographic, clinical, and laboratory data were obtained by consulting Reuma.pt. The diagnosis of SLE induced by anti-TNFα was considered if there was a temporal relationship between the onset of anti-TNFα therapy and manifestations (clinical and immunological) in accordance with the American College of Rheumatology/European League Against Rheumatism criteria (2019). A total of 607 patients with inflammatory rheumatic diseases and six cases of SLE induced by anti-TNF-α therapy were reviewed: two patients were affected by RA, three patients by SpA, and one by PsA. All these patients had articular and constitutional symptoms that improved after discontinuation of the anti-TNFα agent. After switching to a second anti-TNFα agent, there was no recurrence of SLE over time. The development of SLE secondary to anti-TNFα agents in inflammatory rheumatic patients is rare. In this case series, all patients had a mild disease that improved after therapy discontinuation without recurrence of the disease. SLE induced by anti-TNFα should be considered in the follow-up of RA, SpA, and PsA patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Lucas应助科研通管家采纳,获得10
刚刚
丘比特应助科研通管家采纳,获得30
刚刚
guojingjing发布了新的文献求助10
刚刚
小蘑菇应助科研通管家采纳,获得10
刚刚
赘婿应助科研通管家采纳,获得10
刚刚
慕青应助科研通管家采纳,获得10
刚刚
思源应助科研通管家采纳,获得10
刚刚
猪猪hero应助科研通管家采纳,获得10
刚刚
毛豆应助科研通管家采纳,获得20
刚刚
Ava应助科研通管家采纳,获得10
刚刚
猪猪hero应助科研通管家采纳,获得10
刚刚
是木易呀应助科研通管家采纳,获得10
刚刚
香蕉觅云应助科研通管家采纳,获得10
1秒前
Akim应助科研通管家采纳,获得10
1秒前
无私语儿完成签到,获得积分20
1秒前
清风在侧发布了新的文献求助10
1秒前
1秒前
无花果应助不安的依风采纳,获得10
1秒前
2秒前
haha完成签到,获得积分20
2秒前
鸭屎香菜发布了新的文献求助10
2秒前
2秒前
2秒前
3秒前
风筝鱼发布了新的文献求助20
3秒前
香菜完成签到 ,获得积分10
4秒前
fei完成签到,获得积分10
4秒前
4秒前
林小锋发布了新的文献求助10
4秒前
NexusExplorer应助小晴天采纳,获得10
4秒前
慕青应助111采纳,获得10
5秒前
5秒前
醉熏的盼曼完成签到,获得积分20
5秒前
5秒前
6秒前
充电宝应助白月当归采纳,获得10
6秒前
javascript发布了新的文献求助10
6秒前
Lalali发布了新的文献求助10
7秒前
淡然篮球完成签到,获得积分10
7秒前
高分求助中
Continuum thermodynamics and material modelling 3000
Production Logging: Theoretical and Interpretive Elements 2500
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 2000
Applications of Emerging Nanomaterials and Nanotechnology 1111
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Theory of Block Polymer Self-Assembly 750
지식생태학: 생태학, 죽은 지식을 깨우다 700
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3474135
求助须知:如何正确求助?哪些是违规求助? 3066512
关于积分的说明 9099287
捐赠科研通 2757760
什么是DOI,文献DOI怎么找? 1513110
邀请新用户注册赠送积分活动 699386
科研通“疑难数据库(出版商)”最低求助积分说明 698921